We are happy to announce opening of a new clinical site for MonTas phase I clinical trial testing MBS8. We are delighted to wellcome Director MD, PhD, Emiliano Calvo and his START Madrid-HM CIOCC Early Phase Program https://lnkd.in/eTAqzPkK
Dr. Calvo is not only an excellent and friendly investigator, but also a very experienced Key Opinion Leader in his field within experimental oncology and immuno oncology. The first patient was treated with MBS8 last week, and we wish all the best for a positive outcome.
